Endurant Capital Management LP - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$336,422
-64.9%
20,754
-63.9%
0.29%
-40.2%
Q1 2023$957,125
-76.5%
57,485
-86.7%
0.49%
-70.2%
Q4 2022$4,070,529
+129.5%
433,035
+142.7%
1.65%
+135.8%
Q1 2019$1,774,000
+333.7%
178,448
+233.8%
0.70%
+224.5%
Q4 2018$409,000
-67.4%
53,466
-25.7%
0.22%
-61.3%
Q3 2018$1,254,000
+118.5%
71,977
+19.0%
0.56%
+124.1%
Q2 2018$574,000
+10.4%
60,499
-49.2%
0.25%
+28.4%
Q1 2018$520,000119,1000.19%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders